Skip to Content


In the US, Tambocor (flecainide systemic) is a member of the drug class group I antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia, Supraventricular Tachycardia, Ventricular Tachycardia and Wolff-Parkinson-White Syndrome.

US matches:

UK matches:

Ingredient matches for Tambocor


Flecainide is reported as an ingredient of Tambocor in the following countries:

  • Iceland

Flecainide acetate (a derivative of Flecainide) is reported as an ingredient of Tambocor in the following countries:

  • Australia
  • Belgium
  • Chile
  • Costa Rica
  • Denmark
  • Egypt
  • El Salvador
  • Estonia
  • Finland
  • Germany
  • Greece
  • Guatemala
  • Honduras
  • Hong Kong
  • Ireland
  • Israel
  • Japan
  • Malaysia
  • Malta
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Panama
  • Philippines
  • Romania
  • South Africa
  • South Korea
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.